JBS JBS N.V. IFRS
Meat Packing Plants · NYSE · SEC CIK 1791942
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY11.7%
TTM net income YoY14.6%
TTM EPS YoY14.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin13.1%
Operating margin4.8%
Net margin2.3%
FCF margin1.0%
EBITDA margin7.5%
Returns
ROE25.6%
ROA4.7%
ROIC (approx.)15.4%
Asset turnover2.01x
Leverage & solvency
Liabilities / assets78.9%
Debt / equity2.42x
Current ratio1.60x
Interest coverage2.48x
Cash quality & payout
Operating cash flow / net income1.45x
Accruals ratio-2.1%
Payout ratio77.7%
Capex / revenue2.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | $86.18B | $77.18B | $72.92B |
| Cost of revenue | $74.88B | $65.59B | $64.95B |
| Gross profit | $11.30B | $11.59B | $7.97B |
| SG&A expense | $2.19B | $2.28B | $2.32B |
| Operating income | $4.16B | $4.38B | $1.08B |
| Interest expense | $1.68B | $1.65B | $1.73B |
| Pretax income | $2.62B | $2.71B | -$259.73M |
| Income tax | $390.51M | $743.39M | -$127.99M |
| Net income | $2.02B | $1.77B | -$198.87M |
| EBITDA | $6.47B | $6.57B | $3.23B |
| EPS (basic) | 1.89 | 1.65 | -0.19 |
| EPS (diluted) | 1.89 | 1.65 | -0.19 |
| Banking | |||
| Net interest income | $182.28M | $253.73M | $102.50M |
| Balance sheet | |||
| Cash & equivalents | $4.57B | $5.61B | $4.57B |
| Short-term investments | $454.78M | $303.19M | — |
| Receivables | $4.23B | $3.74B | — |
| Inventory | $6.11B | $5.02B | — |
| Current assets | $18.44B | $17.12B | — |
| PP&E, netmay include right-of-use assets (IFRS) | $13.65B | $11.78B | $12.92B |
| Goodwill | $5.85B | $5.42B | — |
| Intangibles | $1.83B | $1.80B | $1.99B |
| Total assets | $45.16B | $40.69B | — |
| Current liabilities | $11.54B | $11.66B | — |
| Short-term debt | $833.09M | $2.08B | — |
| Long-term debt | $20.26B | $17.24B | — |
| Total debt | $21.09B | $19.33B | — |
| Total liabilities | $35.63B | $32.55B | — |
| Shareholders' equity | $8.70B | $7.09B | $9.71B |
| Net debt | $16.53B | $13.71B | — |
| Shares outstanding | 1.11B | — | — |
| Cash flow statement | |||
| Operating cash flow | $2.93B | $4.23B | $2.38B |
| Capital expenditure | $2.10B | $1.48B | $1.50B |
| Free cash flow | $832.68M | $2.75B | $876.64M |
| Investing cash flow | -$2.31B | -$1.42B | -$1.41B |
| Financing cash flow | -$1.77B | -$1.41B | $1.02B |
| Depreciation & amortization | $2.31B | $2.19B | $2.15B |
| Stock-based compensation | $28.85M | $15.79M | $6.91M |
| Dividends paid | $1.57B | $759.30M | $447.98M |
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.